Treatment of Lyme disease

M. B. Salzman, S. K. Sood, Norman Todd Ilowite, E. Hilton, L. G. Rubin

Research output: Contribution to journalArticle

Abstract

Antimicrobial therapy is usually effective in the treatment of Lyme borreliosis. Doxycycline and amoxicilline are the preferred oral agents of choice while ceftriaxone is used when parenteral therapy is necessary. The most appropriate duration of antibiotic therapy for different manifestations of Borrelia burgdorferi infection are not established but recent trends suggest that longer durations of therapy (21-30 days) may be beneficial. Recommendations are made for the initial therapy for different manifestations of this infection.

Original languageEnglish (US)
Pages (from-to)185-191
Number of pages7
JournalChildren's Hospital Quarterly
Volume3
Issue number3
StatePublished - 1991
Externally publishedYes

Fingerprint

Lyme Disease
Borrelia Infections
Therapeutics
Borrelia burgdorferi
Ceftriaxone
Doxycycline
Amoxicillin
Anti-Bacterial Agents
Infection

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Salzman, M. B., Sood, S. K., Ilowite, N. T., Hilton, E., & Rubin, L. G. (1991). Treatment of Lyme disease. Children's Hospital Quarterly, 3(3), 185-191.

Treatment of Lyme disease. / Salzman, M. B.; Sood, S. K.; Ilowite, Norman Todd; Hilton, E.; Rubin, L. G.

In: Children's Hospital Quarterly, Vol. 3, No. 3, 1991, p. 185-191.

Research output: Contribution to journalArticle

Salzman, MB, Sood, SK, Ilowite, NT, Hilton, E & Rubin, LG 1991, 'Treatment of Lyme disease', Children's Hospital Quarterly, vol. 3, no. 3, pp. 185-191.
Salzman MB, Sood SK, Ilowite NT, Hilton E, Rubin LG. Treatment of Lyme disease. Children's Hospital Quarterly. 1991;3(3):185-191.
Salzman, M. B. ; Sood, S. K. ; Ilowite, Norman Todd ; Hilton, E. ; Rubin, L. G. / Treatment of Lyme disease. In: Children's Hospital Quarterly. 1991 ; Vol. 3, No. 3. pp. 185-191.
@article{b83cff77d46a4d4da7f4adaa7f1c5ad9,
title = "Treatment of Lyme disease",
abstract = "Antimicrobial therapy is usually effective in the treatment of Lyme borreliosis. Doxycycline and amoxicilline are the preferred oral agents of choice while ceftriaxone is used when parenteral therapy is necessary. The most appropriate duration of antibiotic therapy for different manifestations of Borrelia burgdorferi infection are not established but recent trends suggest that longer durations of therapy (21-30 days) may be beneficial. Recommendations are made for the initial therapy for different manifestations of this infection.",
author = "Salzman, {M. B.} and Sood, {S. K.} and Ilowite, {Norman Todd} and E. Hilton and Rubin, {L. G.}",
year = "1991",
language = "English (US)",
volume = "3",
pages = "185--191",
journal = "Children's Hospital Quarterly",
issn = "0899-5869",
publisher = "Kluwer/Plenum Publishers",
number = "3",

}

TY - JOUR

T1 - Treatment of Lyme disease

AU - Salzman, M. B.

AU - Sood, S. K.

AU - Ilowite, Norman Todd

AU - Hilton, E.

AU - Rubin, L. G.

PY - 1991

Y1 - 1991

N2 - Antimicrobial therapy is usually effective in the treatment of Lyme borreliosis. Doxycycline and amoxicilline are the preferred oral agents of choice while ceftriaxone is used when parenteral therapy is necessary. The most appropriate duration of antibiotic therapy for different manifestations of Borrelia burgdorferi infection are not established but recent trends suggest that longer durations of therapy (21-30 days) may be beneficial. Recommendations are made for the initial therapy for different manifestations of this infection.

AB - Antimicrobial therapy is usually effective in the treatment of Lyme borreliosis. Doxycycline and amoxicilline are the preferred oral agents of choice while ceftriaxone is used when parenteral therapy is necessary. The most appropriate duration of antibiotic therapy for different manifestations of Borrelia burgdorferi infection are not established but recent trends suggest that longer durations of therapy (21-30 days) may be beneficial. Recommendations are made for the initial therapy for different manifestations of this infection.

UR - http://www.scopus.com/inward/record.url?scp=0026403524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026403524&partnerID=8YFLogxK

M3 - Article

VL - 3

SP - 185

EP - 191

JO - Children's Hospital Quarterly

JF - Children's Hospital Quarterly

SN - 0899-5869

IS - 3

ER -